» Articles » PMID: 11781229

Differential Gene Expression Profiling of Adult Murine Hematopoietic Stem Cells

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2002 Jan 10
PMID 11781229
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Hematopoietic stem cells (HSCs) have self-renewal capacity and multilineage developmental potentials. The molecular mechanisms that control the self-renewal of HSCs are still largely unknown. Here, a systematic approach using bioinformatics and array hybridization techniques to analyze gene expression profiles in HSCs is described. To enrich mRNAs predominantly expressed in uncommitted cell lineages, 54 000 cDNA clones generated from a highly enriched population of HSCs and a mixed population of stem and early multipotent progenitor (MPP) cells were arrayed on nylon membranes (macroarray or high-density array), and subtracted with cDNA probes derived from mature lineage cells including spleen, thymus, and bone marrow. Five thousand cDNA clones with very low hybridization signals were selected for sequencing and further analysis using microarrays on glass slides. Two populations of cells, HSCs and MPP cells, were compared for differential gene expression using microarray analysis. HSCs have the ability to self-renew, while MPP cells have lost the capacity for self-renewal. A large number of genes that were differentially expressed by enriched populations of HSCs and MPP cells were identified. These included transcription factors, signaling molecules, and previously unknown genes.

Citing Articles

TET2 deficiency increases the competitive advantage of hematopoietic stem and progenitor cells through upregulation of thrombopoietin receptor signaling.

Yang Y, Cathelin S, Liu A, Subedi A, Maher A, Hosseini M Nat Commun. 2025; 16(1):2384.

PMID: 40064887 PMC: 11894142. DOI: 10.1038/s41467-025-57614-y.


Ing4-deficiency promotes a quiescent yet transcriptionally poised state in hematopoietic stem cells.

Thompson Z, Anderson G, Hernandez M, Quinde C, Marchione A, Rodriguez M iScience. 2024; 27(8):110521.

PMID: 39175773 PMC: 11340613. DOI: 10.1016/j.isci.2024.110521.


Cyclin-dependent kinase inhibitors in malignant hematopoiesis.

Schirripa A, Sexl V, Kollmann K Front Oncol. 2022; 12:916682.

PMID: 36033505 PMC: 9403899. DOI: 10.3389/fonc.2022.916682.


Expanded circulating hematopoietic stem/progenitor cells as novel cell source for the treatment of TCIRG1 osteopetrosis.

Capo V, Penna S, Merelli I, Barcella M, Scala S, Basso-Ricci L Haematologica. 2020; 106(1):74-86.

PMID: 31949009 PMC: 7776247. DOI: 10.3324/haematol.2019.238261.


Constitutive Activation of NF-κB Pathway in Hematopoietic Stem Cells Causes Loss of Quiescence and Deregulated Transcription Factor Networks.

Nakagawa M, Chen H, Rathinam C Front Cell Dev Biol. 2018; 6:143.

PMID: 30425986 PMC: 6218573. DOI: 10.3389/fcell.2018.00143.